Post by
HTNYC1 on Dec 18, 2020 2:57pm
Bringing back the Empower Math
I posted this a few days ago based on a few things the CEO said but worth bringing back here - sourced from prior CEO interviews and the Empower Investor Deck:
- 4000 per day testing capability but can increase it quite easily
- ~$100 CAD revenue per test but potentially lower for bulk orders
- Currently valued at 6x forward earnings multiplier, Teladoc et al get ~40
- Current valuation ~$56m CAD as per current stock price
Discounting the rest of the business entirely and setting the ave. revenue per test at $100 CAD and keeping the multiplier at 6x you get the following over the next 12 months:
10% lab utilization: $14.4m rev @ an $86.4m valuation (1.5x current share price fully diluted)
25% lab utilization: $36m rev @ a $216m valuation (4x current share price fully diluted)
50% lab utilization: $72m rev @ a $416m valuation (8x current share price fully diluted)
100% lab utilization $144m rev @ an $832m valuation (15x current share price fully diluted)
Put simply - if they do nothing except sell and process 400 tests a day in 2021 this business is 50% undervalued
I'm obviously being overly simplistic here and leaving out a lot but suffice to say I'll be buying more first thing on Monday.
GLTA
Comment by
whateveryousay on Dec 18, 2020 10:37pm
Hopefully people will at least agree to testing and masks forget the vaccine over 60% of americans are anti vaccine.
Comment by
whateveryousay on Dec 19, 2020 2:57pm
They are signing on big corporations who will have regular testing probably for a couple of years it looks like a good business model.
Comment by
Alioops15 on Dec 19, 2020 5:42pm
All valid points. Our greatest problem will not be the distribution of vaccines and the time it takes to get to the needed 70 percent vaccinaton level but all the misinformation that will occur and be accepted as truth along the way. If a lie is repeated often enough there will be some people that will accept it as the truth without question.
Comment by
north40 on Dec 19, 2020 8:54pm
Pfizer's CEO said it's not clear if the company's coronavirus vaccine will no longer be able to spread the virus to other people.